Clinical Trials Logo
  1. Home
  2. Mental Retardation
  3. NCT01908400

Safety and Efficacy of BMMNCin Patients With Mental Retardation

Mental Retardation Clinical Trial

Official title:
An Open Labeled Clinical Study to Evaluate the Safety and Efficacy of Autologous Bone Marrow Derived Mono Nuclear Stem Cell (BMMNCs) in Patients With Mental Retardation. It is Self Funded (Patients' Own Funding) Clinical Trial

Clinical Trial Summary

Mental retardation is a condition diagnosed before age 18 that includes below-average general intellectual function, and a lack of the skills necessary for daily living. Mental retardation affects about 1 - 3% of the population. There are many causes of mental retardation, but find a specific reason in only 25% of cases.Bone marrow derived stem cells are used in this condition to prove its safety and efficacy .

Clinical Trial Description

n/a

Study Design

Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT01908400
Study type Interventional
Source Chaitanya Hospital, Pune
Contact Sachin P Jamadar, D.Ortho
Phone 918888788880
Email sac2751982@gmail.com
Status Recruiting
Phase Phase 1/Phase 2
Start date September 2014
Completion date November 2016
View Details
See also
  Status Clinical Trial Phase
Completed NCT02791321 - Fragility Assessment in Adults With ADHD and Mental Retardation N/A
Withdrawn NCT02245724 - Stem Cell Therapy in Mental Retardation Phase 1
Completed NCT00156221 - MR Scanning of Very Young Children With Severe Developmental Disorders N/A
Recruiting NCT00491478 - Repetitive Behavior Disorders in People With Severe Mental Retardation Phase 3
Terminated NCT02797418 - "Cognitus & Moi": a New Cognitive Remediation Tool N/A
Completed NCT00758108 - Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
Completed NCT01430845 - Predicting Developmental Disability Type and Mental Retardation Level in Children With General Developmental Delay
Not yet recruiting NCT02214745 - Demographic Characteristics of Children Suffering From Mental Retardation or Cerebral Palsy in the Israeli Arab Community N/A
Active, not recruiting NCT00552526 - Ketogenic Diet vs.Antiepileptic Drug Treatment in Drug Resistant Epilepsy Phase 4
Completed NCT02943304 - Neurodevelopment Outcome of Newborns Exposed to Zika Virus (ZIKV) in Utero
Completed NCT00491894 - Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions Phase 3
Completed NCT01291238 - School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability. N/A
Completed NCT01456910 - Resistance Training Program, Labor Inclusion, Intellectual Disability N/A
Completed NCT00065273 - Atypical Neuroleptic Drugs in People With Mental Retardation/Developmental Delay Phase 3
Active, not recruiting NCT00065936 - Self-Injury: Diagnosis and Treatment Phase 3
Completed NCT00506259 - Treatment Strategies for Children With Smith-Magenis Syndrome Phase 1
Not yet recruiting NCT05442229 - A Cross-sectional Study to Evaluate Speech and Language Development in Chinese Children Aged 2-6 Years
Active, not recruiting NCT06370793 - Ningbo Severe Mental Disorders Cohort
Completed NCT01517048 - Brain-Derived Neurotrophic Factor in Obesity and Brain Function
Completed NCT03847753 - Exploring the Comorbidity Between Mental Disorders and General Medical Conditions